Improving HIV prevention strategies for people who inject drugs
Optimizing HIV prevention portfolios targeting people who inject drugs using dynamic economic modeling
This study is looking at the best ways to help people who inject drugs stay safe from HIV, using new data and models to find effective and affordable prevention strategies that can be used around the world.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project ID | NIH-10454336 on NIH RePORTER |
What this research studies
This research focuses on enhancing HIV prevention efforts specifically for people who inject drugs (PWID) across 108 countries. By utilizing dynamic economic modeling and newly available global data, the project aims to identify the most effective and cost-efficient strategies to reduce HIV transmission among this high-risk group. The approach involves developing and validating an epidemic model that estimates the impact of various prevention portfolios tailored to the unique needs of PWID. The ultimate goal is to provide policymakers with actionable insights to improve health outcomes for PWID and reduce HIV incidence globally.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who inject drugs and are at risk of HIV infection, particularly in regions with high prevalence rates.
Not a fit: Patients who do not inject drugs or are not at risk of HIV infection may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective HIV prevention strategies that significantly reduce new infections among people who inject drugs.
How similar studies have performed: Previous research has shown success in optimizing public health strategies for infectious diseases using economic modeling, indicating that this approach has potential for impactful results.
Where this research is happening
La Jolla, United States
- University of California, San Diego — La Jolla, United States (Active)
Researchers
- Principal investigator: Martin, Natasha — University of California, San Diego
- Study coordinator: Martin, Natasha
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.